Loading
Yanuki
ARTICLE DETAIL
Allstate Reports $140M February Catastrophe Losses | California's Rising Insurance Costs: The Role of Personal Injury Lawyers | Entergy Launches US$2.18 Billion Equity Raise: What It Means for Investors | Tesla (TSLA) Stock Analysis: Challenges and Rebound Potential in 2026 | Mexican Peso Strengthens as Dollar Falls Amid Optimism | Chip Stock Rebound: Is SMH the Best Play? | Dell: Benefiting from the AI Infrastructure Boom | SanDisk Stock: Recent Volatility and Market Sentiment | Rocket Lab's Valuation: Beyond the Launch Story | Allstate Reports $140M February Catastrophe Losses | California's Rising Insurance Costs: The Role of Personal Injury Lawyers | Entergy Launches US$2.18 Billion Equity Raise: What It Means for Investors | Tesla (TSLA) Stock Analysis: Challenges and Rebound Potential in 2026 | Mexican Peso Strengthens as Dollar Falls Amid Optimism | Chip Stock Rebound: Is SMH the Best Play? | Dell: Benefiting from the AI Infrastructure Boom | SanDisk Stock: Recent Volatility and Market Sentiment | Rocket Lab's Valuation: Beyond the Launch Story

Finance / Insurance

Allstate Reports $140M February Catastrophe Losses

Allstate Corporation (NYSE: ALL) reported estimated catastrophe losses of $140 million for February 2026. This update follows a report of total catastrophe losses of $249 million for January and February combined, after tax. Despite these l...

Allstate (ALL) Reports $140M February Catastrophe Losses
Share
X LinkedIn

allstate insurance
Allstate Reports $140M February Catastrophe Losses Image via Yahoo Finance Singapore

Key Insights

  • Allstate reported $140 million in catastrophe losses for February 2026.
  • Total catastrophe losses for January and February reached $249 million after tax.
  • Total policies in force increased by 2.5% year-over-year, reaching 38.4 million.
  • Auto and homeowners segments drove growth with annual increases of 3% and 2.5%, respectively.
  • KBW reiterated a Buy rating on Allstate with a price target of $260.

In-Depth Analysis

The Allstate Corporation (NYSE:ALL), founded in 1931 and headquartered in Illinois, specializes in auto, home, and life insurance. The recent report of $140 million in catastrophe losses for February is significant, but the company's overall growth in policies suggests resilience.

KBW's reiterated Buy rating and a $260 price target indicate confidence in Allstate's future performance. As of March 31, 2026, 14 of 28 analysts maintain a Buy rating on the stock, with a 1-year median price target of $246.50.

While Allstate faces challenges from unpredictable catastrophe events, its ability to grow its policy base, particularly in the auto and homeowners segments, demonstrates a solid foundation.

Read source article

FAQ

- **Q: What were Allstate's catastrophe losses in February 2026?

**

- **Q: What was the growth in Allstate's total policies in force?

**

- **Q: What is the analyst rating for Allstate?

**

Takeaways

  • Allstate's financial performance is being impacted by catastrophe losses, but the company is also experiencing growth in its policy base.
  • Analyst ratings suggest a positive outlook for Allstate's stock.
  • The company's strength in auto and homeowners insurance segments is driving overall growth.

Discussion

What are your thoughts on Allstate's ability to manage catastrophe losses while maintaining growth? Share this article with others who need to stay ahead of this trend!

Sources

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.